Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

TRPM7 residue S1269 mediates cAMP dependence of Ca2+ influx.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      The nonspecific divalent cation channel TRPM7 (transient receptor potential-melastatin-like 7) is involved in many Ca2+ and Mg2+-dependent cellular processes, including survival, proliferation and migration. TRPM7 expression predicts metastasis and recurrence in breast cancer and several other cancers. In cultured cells, it can induce an invasive phenotype by promoting Ca2+-mediated epithelial-mesenchymal transition. We previously showed that in neuroblastoma cells that overexpress TRPM7 moderately, stimulation with Ca2+-mobilizing agonists leads to a characteristic sustained influx of Ca2+. Here we report that sustained influx through TRPM7 is abruptly abrogated by elevating intracellular levels of cyclic adenosine monophosphate (cAMP). Using pharmacological inhibitors and overexpression studies we show that this blockage is mediated by the cAMP effector Protein Kinase A (PKA). Mutational analysis demonstrates that the Serine residue S1269, which is present proximal to the coiled-coil domain within the protein c-terminus, is responsible for sensitivity to cAMP.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Nature. 2009 Feb 12;457(7231):901-5. (PMID: 19118385)
      Eur J Cell Biol. 2014 Oct;93(10-12):455-65. (PMID: 25073440)
      Med Oncol. 2014 Jul;31(7):51. (PMID: 24952306)
      Science. 1988 Nov 4;242(4879):773-7. (PMID: 2847315)
      Biol Direct. 2007 Jan 12;2:1. (PMID: 17222345)
      Nature. 2001 May 31;411(6837):590-5. (PMID: 11385574)
      Cells. 2014 Jul 30;3(3):751-77. (PMID: 25079291)
      Cardiovasc Drug Rev. 2006 Fall-Winter;24(3-4):261-74. (PMID: 17214602)
      Curr Biol. 2012 May 8;22(9):837-42. (PMID: 22521790)
      Eur J Cancer. 2013 Nov;49(17):3694-707. (PMID: 23910495)
      Nat Methods. 2014 Feb;11(2):175-82. (PMID: 24390440)
      Chembiochem. 2008 Sep 1;9(13):2052-4. (PMID: 18633951)
      Cell Calcium. 2013 Dec;54(6):404-15. (PMID: 24176224)
      Gastroenterology. 2005 Nov;129(5):1504-17. (PMID: 16285951)
      Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E3037-46. (PMID: 23878236)
      Cancer Lett. 2013 Jun 1;333(1):96-102. (PMID: 23353055)
      Cell. 2014 May 22;157(5):1061-72. (PMID: 24855944)
      Nat Cell Biol. 2000 Jan;2(1):25-9. (PMID: 10620803)
      Biochem Biophys Res Commun. 2012 Jan 20;417(3):1030-4. (PMID: 22222377)
      PLoS One. 2015 Apr 14;10(4):e0122513. (PMID: 25875503)
      Oncotarget. 2015 Apr 20;6(11):8760-76. (PMID: 25797249)
      ESC Heart Fail. 2016 Sep;3(3):220-224. (PMID: 27818786)
      Mol Cell Proteomics. 2008 Sep;7(9):1598-608. (PMID: 18463090)
      Proteomics. 2004 Jun;4(6):1633-49. (PMID: 15174133)
      Cell Calcium. 2014 May;55(5):252-60. (PMID: 24680379)
      Nat Rev Mol Cell Biol. 2014 Jul;15(7):427. (PMID: 24938632)
      J Gen Physiol. 2003 Jan;121(1):49-60. (PMID: 12508053)
      Neuron. 2006 Jul 20;51(2):201-12. (PMID: 16846855)
      Nat Neurosci. 2009 Oct;12(10):1300-7. (PMID: 19734892)
      Physiol Rev. 2015 Oct;95(4):1383-436. (PMID: 26400989)
      Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6079-E6088. (PMID: 28696294)
      Curr Biol. 1994 Nov 1;4(11):973-82. (PMID: 7874496)
      Nat Cell Biol. 2002 May;4(5):329-36. (PMID: 11941371)
      Cell Calcium. 2010 May;47(5):425-32. (PMID: 20363498)
      J Biol Chem. 2007 Jan 5;282(1):232-9. (PMID: 17095511)
      Sci Rep. 2017 Feb 21;7:42739. (PMID: 28220887)
      Cancer Res. 2012 Aug 15;72(16):4250-61. (PMID: 22871386)
      Eur J Cell Biol. 2016 Nov;95(11):465-474. (PMID: 27402209)
      Am J Physiol Regul Integr Comp Physiol. 2009 Feb;296(2):R201-7. (PMID: 18799634)
      Sci Rep. 2016 Sep 15;6:33459. (PMID: 27628598)
      Oncogene. 2014 May 1;33(18):2307-16. (PMID: 23686305)
      J Biol Chem. 2011 Nov 11;286(45):39328-35. (PMID: 21926172)
      Cell. 2003 Dec 26;115(7):863-77. (PMID: 14697204)
      EMBO J. 2006 Jan 25;25(2):290-301. (PMID: 16407977)
      J Cell Mol Med. 2018 Dec;22(12):6327-6337. (PMID: 30338939)
      J Hypertens. 2009 Jan;27(1):155-66. (PMID: 19145781)
      J Physiol. 2017 May 15;595(10):3165-3180. (PMID: 28130783)
      Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6009-14. (PMID: 15069188)
    • Accession Number:
      0 (Isoquinolines)
      0 (Protein Kinase Inhibitors)
      0 (Sulfonamides)
      0 (TRPM Cation Channels)
      E0399OZS9N (Cyclic AMP)
      EC 2.7.1.- (Trpm7 protein, mouse)
      EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)
      M876330O56 (N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide)
      SY7Q814VUP (Calcium)
    • Publication Date:
      Date Created: 20190108 Date Completed: 20190923 Latest Revision: 20200309
    • Publication Date:
      20250114
    • Accession Number:
      PMC6322742
    • Accession Number:
      10.1371/journal.pone.0209563
    • Accession Number:
      30615643